KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Raw Materials: 2018-2025

Historic Raw Materials for Twist Bioscience (TWST) over the last 5 years, with Sep 2025 value amounting to $20.2 million.

  • Twist Bioscience's Raw Materials rose 16.60% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 16.60%. This contributed to the annual value of $20.2 million for FY2025, which is 16.60% up from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Raw Materials is $20.2 million, which was up 15.40% from $17.5 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Raw Materials high stood at $33.6 million for Q1 2023, and its period low was $11.4 million during Q1 2021.
  • Over the past 3 years, Twist Bioscience's median Raw Materials value was $21.8 million (recorded in 2024), while the average stood at $22.2 million.
  • Per our database at Business Quant, Twist Bioscience's Raw Materials spiked by 205.19% in 2021 and then tumbled by 35.92% in 2024.
  • Quarterly analysis of 5 years shows Twist Bioscience's Raw Materials stood at $30.3 million in 2021, then grew by 10.62% to $33.6 million in 2022, then declined by 29.22% to $23.8 million in 2023, then crashed by 32.51% to $16.0 million in 2024, then climbed by 16.60% to $20.2 million in 2025.
  • Its Raw Materials stands at $20.2 million for Q3 2025, versus $17.5 million for Q2 2025 and $14.3 million for Q1 2025.